AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Fluxys Belgium SA

Annual / Quarterly Financial Statement Mar 27, 2025

3952_rns_2025-03-27_d12717c0-7565-47fe-95cf-ac484dd18c60.pdf

Annual / Quarterly Financial Statement

Open in Viewer

Opens in native device viewer

27 March 2025 5:45 PM - Regulated information: 2024 Results

Annex

Definition of the financial ratios

EBIT

Earnings Before Interests and Taxes or operating profit/loss from continuing operations plus the result of investments accounted for by the equity method and the dividends received from unconsolidated entities. EBIT is used to monitor the operational performance of the group over time.

EBITDA

Earnings Before Interests, Taxes, Depreciation and Amortisation or operating profit/loss from continuing operations, before depreciation, amortisation, impairment and provisions, plus the result of investments accounted for by the equity method and the dividends received from unconsolidated entities. EBITDA is used to monitor the operational performance of the group over time, without considering non-cash expenses.

Net financial debt

Interest-bearing liabilities (including leases), less regulatory liabilities, cash linked to early refinancing transactions and 75% of the balance of cash, cash equivalents and shortand long-term cash investments (the other 25% is considered as reserve for operational needs and therefore not available for investments). This indicator gives an idea about the amount of interest bearing debt that would remain if all available cash would be used to reimburse loans.

Consolidated Balance Sheet In thousands of €
31-12-2024 31-12-2023
I. Non-current assets 2,006,598 2,073,059
Property, plant and equipment 1,804,302 1,873,286
Intangible assets 29,418 27,238
Right of use assets 28,428 28,580
Investments accounted for using the equity
method
50 50
Other financial assets 108,953 111,210
Other receivables 18,691 21,496
Other non-current assets 16,756 11,199
II. Current assets 1,303,498 1,285,557
Inventories 52,711 50,443
Finance lease receivables 0 1,644
Current tax receivables 8,357 7,071
Trade and other receivables 93,521 102,056
Cash investments 31,672 32,998
Cash and cash equivalents 1,091,543 1,068,227
Other current assets 25,694 23,118
Total assets 3,310,096 3,358,616

Consolidated Balance Sheet In thousands of €
31-12-2024 31-12-2023
I. Equity 603,813 613,413
Equity attributable to the parent company's shareholders 603,090 612,625
Share capital and share premiums 60,310 60,310
Retained earnings and other reserves 542,780 552,315
Non-controlling interests 723 788
II. Non-current liabilities 2,318,379 2,297,633
Interest-bearing liabilities 1,025,275 1,070,311
Regulatory liabilities 1,119,089 1,039,716
Provisions 1,182 3,939
Provisions for employee benefits 45,779 48,455
Other non-current financial liabilities 2,912 4,010
Deferred tax liabilities 124,142 131,202
III. Current liabilities 387,904 447,570
Interest-bearing liabilities 56,346 55,336
Regulatory liabilities 170,868 219,122
Provisions 0 291
Provisions for employee benefits 3,293 3,508
Current tax payables 4,516 4,248
Trade and other payables 108,959 118,956
Other current liabilities 43,922 46,109
Total liabilities and equity 3,310,096 3,358,616

Consolidated income statement In thousands of €
31-12-2024 31-12-2023
Operating revenue 608,789 592,788
Sales of gas related to balancing operations and operational
needs
84,152 160,761
Other operating income 20,491 19,594
Consumables, merchandise and supplies used -13,012 -8,895
Purchase of gas related to balancing of operations and
operational needs
-71,635 -157,389
Miscellaneous goods and services -179,034 -179,845
Employee expenses -141,877 -135,240
Other operating expenses -5,591 -5,965
Depreciations -177,533 -166,894
Provisions 2,958 -745
Impairment losses 6,223 11,400
Operational profit/loss 133,931 129,570
Change in the fair value of financial instruments -66 262
Financial income 45,808 37,606
Finance costs -72,038 -70,777
Profit/loss before taxes 107,635 96,661
Income tax expenses -25,574 -19,238
Net profit/loss for the period 82,061 77,423
Fluxys Belgium share 82,913 77,423
Non-controlling interests -852 0
Basic earnings per share attributable to the parent company's
shareholders in €
1.1800 1,1019
Diluted earnings per share attributable to the parent company's
shareholders in €
1.1800 1,1019

Consolidated statement of comprehensive income In thousands of €
31-12-2024 31-12-2023
Net profit/loss for the period 82.061 77,423
Items that will not be reclassified
subsequently to profit or loss
Remeasurements of employee benefits 7.925 -13,394
Income tax expense on these variances -2.006 3,348
Other comprehensive income 5.919 -10,046
Comprehensive income for the period 87.980 67,377
Fluxys Belgium share 88.832 67,377
Non-controlling interests -852 0

Consolidated statement of changes in equity In thousands of €
Share
capital
Share
pre
mium
Reserves
not
available
for
distribu
tion
Retained
earnings
Reserves
for
employee
benefits
Other
compre
hensive
income
Equity
attributable
to the parent
company's
share
holders
Non
con
trolling
interests
Total
equity
I. BALANCE AS AT
31-12-2022
60,272 38 54,072 508,560 20,675 0 643,617 0 643,617
1. Comprehensive
income for the
Period
77,423 -10,046 67,377 67,377
2. Dividends paid -98,369 -98,369 -98,369
3. Capital
increases
788 788
II. CLOSING
BALANCE AS
AT 31-12-2023
60,272 38 54,072 487,614 10,629 0 612,625 788 613,413
1. Comprehensive
income for the
Period
82,913 5,919 88,832 -852 87,980
2. Dividends paid -98,367 -98,367 -98,367
3. Capital
increases
787 787
III. CLOSING
BALANCE AS AT
31-12-2024
60,272 38 54,072 472,160 16,548 0 603,090 723 603,813
Consolidated statement of cash flows (indirect method) In thousands of €
31-12-2024 31-12-2023
I. Cash and cash equivalents, opening balance 1,068,227 1,070,708
II. Net cash flows from operating activities 303,095 356,266
1. Cash flows from operating activities 292,095 345,568
1.1. Profit/loss from continuing operations 133,931 129,569
1.2. Non cash adjustments 157,991 447,983
1.2.1. Depreciations 177,533 166,894
1.2.2. Provisions -6,613 745
1.2.3. Impairment losses -6,223 -11,400
1.2.4. Other non-cash adjustments -135 640
1.2.5. Increase (decrease) of the regulatory liabilities -6,571 291,104
1.3. Changes in working capital 173 -231,984
1.3.1. Decrease (increase) of inventories 4,084 23,644
1.3.2. Decrease (increase) of tax receivables -1,286 901
1.3.3. Decrease (increase) of trade and other receivables 13,765 62,264
1.3.4. Decrease (increase) of other current assets -1,959 -7,628
1.3.5. Increase (decrease) of tax payables 268 1,070
1.3.6. Increase (decrease) of trade and other payables -12,065 -333,230
1.3.7. Increase (decrease) of other current liabilities -2,634 20,995
2. Cash flows relating to other operating activities 11,000 10,698
2.1. Current tax paid -34,639 -26,600
2.2. Interests from investments, cash and cash equivalents 45,452 36,689
2.3. Other inflows (outflows) relating to other operating
activities
187 609
III. Net cash flows relating to investment activities -102,441 -177,564
1. Acquisitions -111,834 -185,595
1.1. Payments to acquire property, plant and equipment,
and intangible assets
-103,852 -184,776
1.2. Payments to acquire other financial assets -7,982 -819

Consolidated statement of cash flows (indirect method) In thousands of €
31-12-2024 31-12-2023
2. Disposals 8,067 14,916
2.1. Proceeds from disposal of property, plant and
equipment, and intangible assets
933 2,916
2.2. Proceeds from disposal of other financial assets 7,134 12,000
3. Increase (-)/ Decrease (+) of cash investments 1,326 -6,885
IV. Net cash flows relating to financing activities -177,338 -181,183
1. Proceeds from cash flows from financing 2,431 1,238
1.1. Proceeds from issuance of equity instruments 787 788
1.2. Proceeds from finance leases 1,644 450
2. Repayments relating to cash flows from financing -48,484 -49,411
2.1. Repayment of finance lease liabilities -5,248 -5,048
2.2. Repayment of other financial liabilities -43,236 -44,363
3. Interests -32,918 -34,641
3.1. Interest paid classified as financing -32,918 -34,680
3.2. Interest received classified as financing 0 39
4. Dividends paid -98,367 -98,369
V. Net change in cash and cash equivalents 23,316 -2,481
VI. Cash and cash equivalents, closing balance 1,091,543 1,068,227
Fluxys Belgium consolidated income
statement in thousands of €
31-12-2024 31-12-2023
Operating profit/loss 133,931 129,570
Depreciations 177,533 166,894
Provisions -2,958 745
Impairment losses -6,223 -11,400
Earnings from associates and joint ventures 0 0
Dividends from unconsolidated entities 0 0
EBITDA in thousands of € 302,283 285,809
Fluxys Belgium consolidated income
statement in thousands of €
31-12-2024 31-12-2023
Operating profit/loss 133,931 129,570
Earnings from associates and joint ventures 0 0
Dividends from unconsolidated entities 0 0
EBIT in thousands of € 133,931 129,570
Fluxys Belgium consolidated balance
sheet in thousands of €
31-12-2024 31-12-2023
Non-current interest-bearing liabilities 1,025,275 1,070,311
Current interest-bearing liabilities 56,346 55,336
Cash investments (75%) -23,754 -24,749
Cash and cash equivalents (75%) -818,657 -801,170
Other financial assets (75%) -79,460 -80.324
Net financial debt in thousands of € 159,750 219,404

Talk to a Data Expert

Have a question? We'll get back to you promptly.